Introduction:
GeneFab plans to construct a state-of-the-art cGMP facility in California, USA, dedicated to the diverse spectrum of genetic medicines.
Features:
This state-of-the-art facility will provide groundbreaking services in the realms of manufacturing and synthetic biology design, catering to a wide spectrum of genetic medicine needs.
The forthcoming cGMP facility, spans an impressive 92,000 square feet. Within this cutting-edge establishment, a substantial 42,000 square feet is exclusively reserved for the production of pioneering Phase 1/2 clinical trial materials.
This cutting-edge facility is well-equipped to support complex cell and gene therapy manufacturing. This includes meeting the needs for different types of cell therapy (allogeneic and autologous), producing viral vectors, and providing essential cell banking services.
The use of advanced capabilities and skills transforms the scientific innovation into tangible treatments, and provides life-changing therapies to patients in need.
Specifications:
Name GeneFab
Type New Construction
